HUM Humana Inc.
USHealthcareAs of 2026-10-09 12:28
Why HUM matters now
Humana Inc. (HUM) is a US stock in Healthcare. The latest InvestLog snapshot shows $435.74 with +12.56% on the session and $52.32B in market capitalization; recent performance reads 1-month +16.13% and YTD +40.81%.
The latest financial table shown here is Q1 2026, with revenue of $39.65B, net income of $1.19B, and EPS of $9.83. Investors can compare that operating picture with valuation signals such as P/E 19.51 and FCF yield 2.9%.
InvestLog's latest related AI research is a Rating Change note titled "Oppenheimer raises HUM target to $475 from $405". The latest indexable market news headline is "Humana Faces Medicare ‘Stars' Rating. The Result Will Test the Stock." from Barrons.
Additional event context on this page matters because analyst consensus is Hold with a median target of $264.50; recent insider activity includes Martin Aaron filing A-Award; recent congressional disclosure data includes Michael McCaul Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
19.51
PEG
—
P/B
2.34
P/S
0.32
EV/EBITDA
18.36
DCF Value
$735.63
FCF Yield
2.9%
Div Yield
1.0%
Margins & Returns
Gross Margin
14.0%
Operating Margin
1.0%
Net Margin
0.8%
ROE
6.2%
ROA
2.0%
ROIC
3.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $39.65B | $1.19B | $9.83 |
| Q4 2025 | $32.52B | $-796.0M | $-6.61 |
| FY 2025 | $129.66B | $1.19B | $9.84 |
| Q3 2025 | $32.65B | $195.0M | $1.62 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$298.50
Target (Median)
$264.50
Target Range
$195.00 - $441.00
Trading Activity
Insider Trades
Congress Trades
Related AI Research
Oppenheimer raises HUM target to $475 from $405Oppenheimer 上调目标价 休曼纳公司 (HUM):$405 → $475
On 2026-10-09, Oppenheimer raised its HUM price target to $475 from $405 (+17.3%).Oppenheimer 于 2026-10-09 将 HUM 目标价上调至 $475,此前为 $405,变动幅度 +17.3%。
Baird upgrades HUM from Neutral to OutperformBaird 把 休曼纳公司 (HUM) 评级 上调:中性(Neutral) → 跑赢大市(Outperform)
On 2026-10-09, Baird upgraded HUM to Outperform from Neutral.Baird 于 2026-10-09 将 HUM 评级上调至 跑赢大市(Outperform),此前为 中性(Neutral)。
Barclays raises HUM target to $582 from $515Barclays 上调目标价 休曼纳公司 (HUM):$515 → $582
On 2026-10-09, Barclays raised its HUM price target to $582 from $515 (+13.0%).Barclays 于 2026-10-09 将 HUM 目标价上调至 $582,此前为 $515,变动幅度 +13.0%。
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Plans
Country
US
Exchange
—
Beta
0.77
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.